Quantcast
Last updated on April 23, 2014 at 16:13 EDT

Latest Lymphocyte Stories

2014-03-06 23:22:54

Over the last decade, much knowledge has been gained regarding the genetic events that drive leukemia; the exact cell of origin, however, remains largely unknown. This study suggests that there may be subsets of cells at increased risk of developing leukemia. (PRWEB) March 06, 2014 Researchers at the University of Virginia School of Medicine have discovered a specific type of immune cell in the bone marrow of mice responsible for an aggressive, poorly understood form of leukemia. The...

2014-02-18 08:30:40

LONDON, Feb. 18, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:The Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells: Emerging Opportunities for the Biopharmaceutical IndustryA comparative analysis and assessment of TCR technologies, pipelines and companies from an industry perspectiveTherapeutic monoclonal antibodies have become an increasingly successful treatment modality with sales of US$ 65 bln in the year 2012 and with an...

2014-01-15 10:42:21

Christopher Parsons, MD, Director of the HIV Malignancies Program at LSU Health Sciences Center New Orleans, is the senior author of a paper that is the first to report that specialized fat (lipid) molecules, called sphingolipids, play a key role in the survival of aggressive lymphomas caused by viruses. The paper also reveals a new therapy for preventing production of sphingolipids by lymphoma cells, thereby killing these cells, which are often resistant to standard therapies. The study is...

Researchers Show B Cells Can Deliver Potentially Therapeutic Bits Of Modified RNA
2013-11-26 06:59:03

University of California - San Diego Researchers at the University of California, San Diego School of Medicine have successfully targeted T lymphocytes – which play a central role in the body's immune response – with another type of white blood cell engineered to synthesize and deliver bits of non-coding RNA or microRNA (miRNA). The achievement in mice studies, published in this week's online early edition of the Proceedings of the National Academy of Sciences, may be the first step...

2013-10-28 08:29:38

Agreement gives PELOBIOTECH exclusive distribution rights to ColonyGEL(TM) media for colony-forming cell assays and primary human cell products for research applications SEATTLE, Oct. 28, 2013 /PRNewswire/ -- ReachBio LLC (Seattle, WA, USA) announced today that it has signed an agreement with PELOBIOTECH GmbH (Munich, Germany) giving PELOBIOTECH exclusive distribution rights to ReachBio's full product line for the life science research market within Germany, Austria and Switzerland....

Fatal Frog Fungus Releases Toxicity That Disables Immune Response
2013-10-18 09:09:21

April Flowers for redOrbit.com - Your Universe Online For the last 40 years, amphibian species around the world have been dying out. A type of chytrid fungus, Batrachochytrium dendrobatidis, was identified in 1998 as causing skin infections in frogs. Since then, it has become recognized as a leading contributor to worldwide amphibian decline. A new study from Vanderbilt University, published in the journal Science, reports that the fungus is killing these animals by releasing a toxic...

2013-10-08 12:27:48

Study co-led by Fred Hutchinson Cancer Research Center dispels notion of immune system as spatially heterogeneous as cancer genome SEATTLE, Oct. 8, 2013 /PRNewswire/ -- Adaptive Biotechnologies Corporation, a leading provider of next-generation oncology diagnostics, today announced results from an ovarian cancer study, conducted in collaboration with Fred Hutchinson Cancer Research Center, highlighting the even distribution of immune fighter cells (T-cells) within the tumor. The...

2013-09-02 19:16:00

A new finding could lead to novel treatments to reduce bleeding in trauma and severe infections. The research, from Oklahoma Medical Research Foundation scientists Lijun Xia, M.D., Ph.D., Jianxin Fu, M.D., Ph.D., and Brett Herzog, Ph.D., appears in the most recent issue of the journal Nature. One way the immune system keeps a body healthy is through immune surveillance. Lymphocytes, a type of white blood cell, constantly exit the bloodstream and "check in" at the lymph nodes to learn...

2013-07-31 08:30:10

Life Technologies' proprietary Dynabeads®CD3/CD28 CTS(TM) utilized to isolate, activate and expand therapeutic T cells for oncology indications CARLSBAD, Calif., July 31, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced that the company has signed a long-term supply and exclusive licensing agreement with Novartis for immunotherapeutics involving T cells modified to express chimeric antigen receptors for the treatment of cancer. Life Technologies...

2013-06-05 08:28:21

STOCKHOLM, June 5, 2013 /PRNewswire/ -- New patents granted in Japan, the USA and Europe SentoClone International AB announced today that it has been granted additional patents in Japan, the US and Europe further reinforcing the global protection of its proprietary SentoClone(R) technology, an active patient specific cellular immunotherapy against cancer based on the ex vivo cultivation and activation of CD4+ T-cells. The technology has advanced to...